Fingerprint
Dive into the research topics of 'Phase 1 study of molibresib (GSK525762), a bromodomain and extra-terminal domain protein inhibitor, in NUT carcinoma and other solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically